Disease phase | No of patients | % of study cohort | Average cost4-150 | Range of costs (min–max) | Cost per cohort member4-151 | % of total disease cost |
Diagnostic phase | 109 | 100% | £2020 | <£132–7569> | £2020 | 17.5% |
1st line treatment | 100 | 92% | £6128 | <£181–14383> | £5622 | 48.7% |
Follow up | 50 | 46% | £1620 | <£70–18661> | £743 | 6.4% |
Re-treatment | 19 | 17% | £5008 | <£353–1655> | £873 | 7.6% |
Follow up | 5 | 5% | £504 | <£72–1655> | £23 | – |
Terminal care | 71 | 65% | £3495 | <£78–9170> | £2275 | 19.6% |
Total | £11556 | 100% |